Humberto Arnés, director general at Farmaindustria, Spain’s leading pharmaceutical industry association, discusses the dynamics of the Spanish pharmaceutical industry showcasing a growth of 2.7 percent of the total public pharmaceutical expenditure while highlighting the association’s strategic plan, revolving around sustainability and access, transparency with healthcare professionals, an increase in industrial activities and focus towards the patient.
The Spanish economy has been expanding at a faster rate than European member states such as France, Germany and the UK since 2015. This is fantastic news for the pharmaceutical industry since, as a regulated sector and one depending on state budget and funding, we directly depend on the economy’s good health
